Jacobs Levy Equity Management Inc. lowered its position in shares of Herbalife Ltd (NYSE:HLF - Free Report) by 18.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,089,454 shares of the company's stock after selling 480,772 shares during the quarter. Jacobs Levy Equity Management Inc. owned 2.05% of Herbalife worth $18,032,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd grew its holdings in shares of Herbalife by 4,406.4% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 4,912 shares of the company's stock valued at $42,000 after buying an additional 4,803 shares during the period. CWM LLC grew its stake in Herbalife by 199.7% in the first quarter. CWM LLC now owns 7,969 shares of the company's stock valued at $69,000 after acquiring an additional 5,310 shares during the period. Bridgefront Capital LLC acquired a new position in Herbalife in the fourth quarter valued at about $71,000. MQS Management LLC acquired a new position in shares of Herbalife in the 1st quarter valued at approximately $105,000. Finally, Cerity Partners LLC acquired a new position in shares of Herbalife in the 1st quarter valued at approximately $108,000.
Herbalife Stock Up 1.7%
HLF traded up $0.16 during trading hours on Friday, hitting $9.51. 507,177 shares of the company's stock were exchanged, compared to its average volume of 2,126,945. Herbalife Ltd has a 1-year low of $5.04 and a 1-year high of $10.83. The stock's 50-day moving average is $9.54 and its two-hundred day moving average is $8.36. The stock has a market cap of $980.89 million, a price-to-earnings ratio of 3.00, a PEG ratio of 0.28 and a beta of 0.89.
Herbalife (NYSE:HLF - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.53 by $0.06. Herbalife had a net margin of 6.59% and a negative return on equity of 27.36%. The business had revenue of $1.26 billion during the quarter, compared to analysts' expectations of $1.27 billion. During the same quarter in the prior year, the company posted $0.54 earnings per share. The firm's revenue was down 1.7% on a year-over-year basis. On average, equities research analysts anticipate that Herbalife Ltd will post 1.57 EPS for the current year.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the stock. Mizuho upped their price target on shares of Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a report on Monday, July 28th. Wall Street Zen lowered shares of Herbalife from a "strong-buy" rating to a "buy" rating in a research note on Sunday, August 10th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $11.50.
Get Our Latest Analysis on Herbalife
About Herbalife
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Stories

Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.